Will FDA approve any mRNA vaccine against glioblastoma before 2028?
6
350Ṁ330
2027
20%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of glioblastoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy